Search results
Early June seeing uptick in summer colds, viruses and COVID-19 cases on LI, doctors say
Newsday· 15 hours agoWhile some of the viruses being seen tend to be more prevalent as summer approaches, possible...
No decline in cardiovascular events seen with COVID-19 vaccine after acute coronary syndromes
Medical Xpress· 3 days agoPatients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not...
Analyzing The Emergence Of Covid Variant KP.2 And Its Potential Impact
Forbes· 7 days agoLike influenza, an easily transmissible respiratory virus, SARS-CoV-2 mutates to evade the immune...
WHO launches dengue dashboard as global threat remains high
Center for Infectious Disease Research and Policy· 7 days agoSo far this year, 90 countries globally have reported active dengue transmission, with the Americas...
COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events
MedPage Today· 7 days agoVIP-ACS trial. Censoring the first 90 days post-vaccination in this non-randomized comparison,...
Health disparities linger in Mississippi for Men’s Health Month
WJTV Jackson· 6 days agoJACKSON, Miss. (WJTV) – As Men’s Health Month begins Saturday, data reveals that their overall...
Singapore slams opposition claims linking Covid vaccines to excess deaths
South China Morning Post· 3 days agoThe health ministry said it categorically rejected the egregious and false claims, adding that...
Penn Medicine Develops Potent mRNA Vaccine Against Lethal H5N1 Virus
SciTechDaily· 5 days agoExperimental mRNA vaccine proves highly effective against H5N1 in animal studies, offering hope for...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
St. Joseph News-Press· 3 days agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies